Skip to search formSkip to main contentSkip to account menu

Dopa

Known as: beta-Hydroxytyrosine, Dihydroxyphenylalanine, 3 Hydroxy DL tyrosine 
A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2005
Highly Cited
2005
One‐third of the 149 people recruited 15 to 18 years ago in the Sydney Multicenter Study of Parkinson's disease have survived… 
Highly Cited
2003
Highly Cited
2003
Long-term treatment with the dopamine precursor levodopa (L-DOPA) induces dyskinesia in Parkinson's disease (PD) patients. We… 
Highly Cited
2002
Highly Cited
2002
3,4-Dihydroxyphenylalanine (DOPA) residues are known for their ability to impart adhesive and curing properties to mussel… 
Highly Cited
1998
Highly Cited
1998
Rats sustaining unilateral near‐complete 6‐hydroxydopamine lesions of the mesostriatal dopamine pathway received daily injections… 
Highly Cited
1990
Highly Cited
1990
Using positron emission tomography (PET), we studied regional striatal 18F‐dopa uptake in 16 patients with L‐dopa‐responsive… 
Highly Cited
1981
Highly Cited
1981
The fouling marine mussel Mytilus edulis attaches itself to various substrates by spinning byssal threads, the adhesive discs of… 
Highly Cited
1971
Highly Cited
1971
  • U. Ungerstedt
  • Acta physiologica Scandinavica. Supplementum
  • 1971
  • Corpus ID: 9882539
A process for the treatment of sewage wherein the sludge is innoculated with a bacteria, L. plantarum, and a carbohydrate such as… 
Highly Cited
1969
Highly Cited
1969
Abstract Slowly increasing oral doses of L-3,4-dihydroxyphenylalanine (L-dopa) induced at least partial improvement of some… 
Highly Cited
1967
Highly Cited
1967
THE known biochemical abnormalities in Parkinson's disease consist of a decrease of melanin pigment in the substantia nigra1 , 2…